In the current study, using hematopoietic-specific Celf2 deletion murine AML models, we observed a strong cooperation between inactivation of Celf2 and MLL-AF9 leading to rapid MA9-induced myeloid leukemia initiation and exacerbated AML progression. The gene discussed is CELF2; the disease is acute myeloid leukemia.